Trial search - ClinicalTrials.eu

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

Study on TAK-861 for Treating Narcolepsy with Cataplexy in Patients

Not yet recruiting

3 1
Investigated Diseases:
- Narcolepsy
Investigated Drugs:
- N-{(2S,3R)-4,4-Difluoro-1-(2-Hydroxy-2-Methylpropanoyl)-2-[(2,3′,5′-Trifluoro[1,1′-Biphenyl]-3-Yl)Methyl]Pyrrolidin-3-Yl}Ethanesulfonamide
+5
A study testing the safety and how the body processes TAK-861 in children and teenagers aged 6 to 17 years with narcolepsy type 1

Not recruiting

1 1 1
Investigated Diseases:
- Narcolepsy
Investigated Drugs:
- N-{(2S,3R)-4,4-Difluoro-1-(2-Hydroxy-2-Methylpropanoyl)-2-[(2,3′,5′-Trifluoro[1,1′-Biphenyl]-3-Yl)Methyl]Pyrrolidin-3-Yl}Ethanesulfonamide
Study on the Safety and Effectiveness of ALKS 2680 for Patients with Narcolepsy Type 2

Not recruiting

2 1
Investigated Diseases:
- Narcolepsy
Investigated Drugs:
- Alks 2680
Study on the Safety and Effectiveness of Pitolisant for Children Aged 6-17 with Narcolepsy, with or without Cataplexy

Not recruiting

3 1 1
Investigated Diseases:
- Narcolepsy
Investigated Drugs:
- Pitolisant
Study on TAK-861 for Treating Narcolepsy with Cataplexy in Patients

Not recruiting

3 1
Investigated Diseases:
- Narcolepsy
Investigated Drugs:
- N-{(2S,3R)-4,4-Difluoro-1-(2-Hydroxy-2-Methylpropanoyl)-2-[(2,3′,5′-Trifluoro[1,1′-Biphenyl]-3-Yl)Methyl]Pyrrolidin-3-Yl}Ethanesulfonamide
Study on Blood Pressure Changes in Narcolepsy Patients Switching from High-Sodium Oxybate to JZP258 (Oxybate Mixed-Salt Formulation)

Not recruiting

3 1 1
Investigated Diseases:
- Narcolepsy
Investigated Drugs:
Study on the Safety and Effectiveness of ALKS 2680 for Patients with Narcolepsy Type 1

Not recruiting

2 1
Investigated Diseases:
- Narcolepsy
Investigated Drugs:
- Alks 2680

Opportunities for Healthy Volunteers

Matched clinical trials

Study on TAK-861 for Treating Narcolepsy with Cataplexy in Patients

A study testing the safety and how the body processes TAK-861 in children and teenagers aged 6 to 17 years with narcolepsy type 1

Study on the Safety and Effectiveness of ALKS 2680 for Patients with Narcolepsy Type 2

Study on the Safety and Effectiveness of Pitolisant for Children Aged 6-17 with Narcolepsy, with or without Cataplexy

Study on TAK-861 for Treating Narcolepsy with Cataplexy in Patients

Study on Blood Pressure Changes in Narcolepsy Patients Switching from High-Sodium Oxybate to JZP258 (Oxybate Mixed-Salt Formulation)

Study on the Safety and Effectiveness of ALKS 2680 for Patients with Narcolepsy Type 1

We use cookies